Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines
Ghaith Bakdash(Radboud University Nijmegen), I. Jolanda M. de Vries(Radboud University Nijmegen)
Cited by 111
Related Papers
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
|Nature Biotechnology|2005|823
Migrating into the Tumor: a Roadmap for T Cells
|Trends in cancer|2017|315
Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity
|OncoImmunology|2016|31
Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites
|Frontiers in Immunology|2019|27
cDC2 plasticity and acquisition of a DC3‐like phenotype mediated by IL‐6 and PGE2 in a patient‐derived colorectal cancer organoids model
|European Journal of Immunology|2024|16